Scarica l'app Stockscreener
0.8696
0.05%
-0.0004
Dopo l'orario di chiusura:
.86
-0.0096
-1.10%
Precedente Chiudi:
$0.87
Aprire:
$0.8585
Volume 24 ore:
52,290
Relative Volume:
0.12
Capitalizzazione di mercato:
$10.13M
Reddito:
$37.17M
Utile/perdita netta:
$-17.57M
Rapporto P/E:
-0.4785
EPS:
-1.8172
Flusso di cassa netto:
$-12.01M
1 W Prestazione:
+1.23%
1M Prestazione:
+11.67%
6M Prestazione:
+3.38%
1 anno Prestazione:
-7.49%
Intervallo 1D:
$0.845
$0.8749
Intervallo di 1 settimana:
$0.8015
$0.8749
Portata 52W:
$0.536
$1.19
Biofrontera Inc Stock (BFRI) Company Profile
Nome
Biofrontera Inc
Settore
Telefono
781-245-1325
Indirizzo
120 PRESIDENTIAL WAY,, WOBURN
Compare BFRI vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BFRI
Biofrontera Inc
|
0.8696 | 10.13M | 37.17M | -17.57M | -12.01M | -1.8172 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.77 | 56.14B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.62 | 48.81B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.03 | 44.67B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.57 | 33.27B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
536.12 | 23.50B | 3.18B | 1.33B | 1.04B | 27.90 |
Biofrontera Inc Borsa (BFRI) Ultime notizie
BFRIWBiofrontera Latest Stock News & Market Updates - Stock Titan
Biofrontera (BFRI) to Release Earnings on Thursday - Defense World
Are healthcare shares trailing behind Align Technology (ALGN) in performance this year? - Bitget
PTA-Adhoc: Biofrontera AG: Financial Guidance for FY 2026 - TradingView
Market Rankings: Is Biofrontera Inc backed by strong institutional buying2026 Opening Moves & Verified Swing Trading Watchlists - baoquankhu1.vn
Biofrontera Inc. (BFRI) Upgraded to Buy: Here's Why - Bitget
Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026 - The Manila Times
Biofrontera to review 2025 results, business update March 19 - Stock Titan
Biofrontera reports Phase 2b acne trial results for Ameluz PDT - Investing.com India
Biofrontera Reports Positive Phase 2b Acne Trial Results - TipRanks
Biofrontera Inc. Reports Positive Phase 2b Results Supporting Further Development of Ameluz® Photodynamic Therapy for moderate to severe Acne Vulgaris - The Manila Times
Biofrontera reports positive Phase 2b Ameluz PDT results for moderate to severe acne - TradingView
Biofrontera Inc. Reports Positive Phase 2b Results - GlobeNewswire
Is Biofrontera Inc. backed by strong institutional buyingQuarterly Portfolio Summary & Safe Entry Trade Reports - baoquankhu1.vn
Loss Report: Does Biofrontera Inc have a sustainable dividendDollar Strength & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Biofrontera Inc. (BFRI) CFO granted RSUs, options and stock conversion - Stock Titan
Biofrontera Inc. (BFRI) director receives 20,000 stock options - Stock Titan
BFRIW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Will Biofrontera Inc. stock go up in YEAR2025 Top Gainers & Risk Controlled Stock Alerts - mfd.ru
Bank Watch: Is Biofrontera Inc a play on infrastructure spendingJuly 2025 Final Week & AI Enhanced Execution Alerts - baoquankhu1.vn
Biofrontera wins patent ruling against Sun Pharma in dispute By Investing.com - Investing.com Canada
Biofrontera wins patent ruling against Sun Pharma in dispute - Investing.com
Biofrontera reports USPTO decision on Sun Pharma’s challenged claims - TipRanks
Biofrontera Wins Key PTAB Ruling in Sun Patent Dispute - TipRanks
Biofrontera (NASDAQ: BFRI) wins PTAB decision on Sun Pharma patent claims - Stock Titan
U.S. Patent Office Issues Final Written Decision Finding - GlobeNewswire
Gains Recap: Will Biofrontera Inc stock go up in YEAR2025 Trading Recap & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Is Biofrontera Inc. stock technically oversoldWeekly Stock Analysis & Community Consensus Trade Signals - mfd.ru
Growth Value: Can Biofrontera Inc Equity Warrant sustain its profitabilityLong Setup & Weekly Breakout Watchlists - baoquankhu1.vn
Trading Action: Does Biofrontera Inc have high return on assets2025 Risk Factors & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Can Biofrontera Inc Equity Warrant sustain its profitabilityMarket Growth Report & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
How Biofrontera Inc. Equity Warrant stock responds to policy changesJuly 2025 Retail & Low Drawdown Momentum Ideas - mfd.ru
Fundamentals Check: Can Biofrontera Inc Equity Warrant navigate macro headwindsQuarterly Profit Report & Safe Entry Trade Reports - baoquankhu1.vn
Biofrontera completes key study for Ameluz skin treatment expansion By Investing.com - Investing.com South Africa
Biofrontera Emerges as Stronger Biotech Stock Compared to RenovaCare - National Today
Biofrontera completes key study for Ameluz skin treatment expansion - Investing.com
Biofrontera Inc (NASDAQ: BFRI) recently announced that the database lock for its Phase I pharmacokinetic study of Ameluz® for actinic keratosis on the trunk and extremities has been completed. - Bitget
Biofrontera Inc. Announces Database Lock of Phase 1 - GlobeNewswire
Travel Stocks: Does Biofrontera Inc have a sustainable dividend2025 Biggest Moves & High Return Trade Opportunity Guides - baoquankhu1.vn
Biofrontera Inc. Announces Database Lock of Phase 1 Pharmacokinetics Study of Ameluz® for Actinic Keratoses on Trunk and Extremities - The Manila Times
Biofrontera reports positive phase 3 data for Ameluz in actinic keratosis - MSN
Bull Run: Is now the right time to enter Biofrontera Inc Equity Warrant - baoquankhu1.vn
BFRI SEC FilingsBiofrontera Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Fundamentals Check: Why ETFs are accumulating Biofrontera AG (B8FK) stockJuly 2025 PostEarnings & Stepwise Trade Execution Plans - mfd.ru
Signal Recap: Is Biofrontera Inc stock a hidden gemTrade Volume Summary & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Is Biofrontera Inc. stock near bottom after declineMarket Trend Review & AI Forecast Swing Trade Picks - mfd.ru
Biofrontera Inc. (NASDAQ:BFRI) Sees Significant Decline in Short Interest - Defense World
Will Biofrontera Inc. Equity Warrant benefit from AI trendsDollar Strength & Scalable Portfolio Growth Methods - mfd.ru
Biofrontera announces FDA filing acceptance of supplemental new drug application for Ameluz® PDT in superficial Basal Cell Carcinoma - marketscreener.com
Biofrontera Announces FDA Filing Acceptance of Supplemental - GlobeNewswire
Biofrontera's light-based option for common skin cancer under FDA review - Stock Titan
Biofrontera Inc Azioni (BFRI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.15%
3.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):